Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.
-
-
ResearchScientific CornerCall for Proposals: Integrating Vascular Architecture into EBRAINS Human Brain Atlas
EBRAINS has announced an open call for proposals aimed at integrating models of the brain's vascular architecture with EBRAIN’s Human Brain Atlas, with the aim of enhancing the usability of brain vasculature data for research and clinical applications, fostering collaboration between institutions and the EBRAINS consortium. -
Paper of the MonthEAN NewsFeatured SliderResearch Paper of the Month: A Monoclonal Antibody to PACAP for Migraine Prevention
Our Paper of the Month for October is a phase 2, double-blind, randomised, placebo-controlled trial investigating the efficacy of a monoclonal antibody (Lu AG09222) that inhibits PACAP signalling. -
Paper of the MonthResearch HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – October 2024
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for October 2024. -
Paper of the MonthEAN NewsFeatured SliderResearch Paper of the Month: Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Our paper of the month for September updates the 2020 Lancet Commission report on the identification of risk factors for dementia, adding two more risk factors to the list. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for September 2024. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
Our paper of the month for August is a randomised controlled trial evaluating tenecteplase administered 4.5 to 24 hours after stroke onset in 516 Chinese patients. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for August 2024.
-
The European Platform for Neurodegenerative Diseases project has launched an open call for expressions of interest to leverage biosamples and datasets catalogued on its platform. -
Results of a short survey conducted among EAN panel members about their competence, interest, and knowledge of the new connectomics methods for studying clinical conditions -
EAN NewsResearchEAN NEuro-covid ReGistrY (ENERGY) reaches 4,000 patients and welcomes interested parties for statistical analyses.
An update on the ENERGY project, which has to date welcomed 96 principal investigators and project members from 44 centres, mainly located in Europe, and included data for more than 4,000 patients. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology
Our paper of the month is an observational cohort study exploring the link between sleep measures and AD pathology in 319 participants (mean ± SD age: 61.5 ± 5.4 years; 47% female) from the Rotterdam Study, a prospective population-based study conducted in the Netherlands. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for July 2024.
-
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Ghrelin for Neuroprotection in Post-Cardiac Arrest Coma
Our paper of the month reports the result of a trial investigating the safety and the potential efficacy of intravenous treatment with acyl-ghrelin in improving neurological outcome in patients in a coma after cardiac arrest. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2024.